指南与共识流行病学与生物统计临床试验与 GCP

美国预防服务工作组肺癌筛查推荐声明(2021)

Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.
指南 / 共识 · JAMA · 2021-01-01

美国预防服务工作组(USPSTF)基于系统综述与协作建模研究更新2013年推荐,将肺癌低剂量CT(LDCT)年度筛查人群扩大至50至80岁、吸烟史≥20包年且目前吸烟或戒烟不足15年者,判定为中等净获益(B级推荐)。

要点

  • 50至80岁、≥20包年吸烟史且现吸烟或戒烟<15年者,推荐每年LDCT筛查(B级)。
  • 戒烟满15年或出现严重限制预期寿命/无法耐受治愈性肺手术的健康问题时应停止筛查。
  • 本推荐替代2013年版(55至80岁、≥30包年)标准。

核心结论

  • USPSTF以中等确定性认定,对基于年龄、累积吸烟暴露与戒烟年限的高危人群,每年LDCT筛查具有中等净获益(B级推荐)。

研究设计与样本

  • USPSTF委托系统综述评估LDCT筛查准确性及获益与危害,并委托协作建模研究比较不同筛查策略与多变量风险预测模型改良版的获益与危害。

主要发现

  • 肺癌为美国第二常见癌症和癌症死亡首位原因;2020年估计228 820人被诊断、135 720人死于该病。
  • 肺癌总体5年生存率为20.5%,早期肺癌预后更好且更适于治疗。
  • 吸烟是肺癌最重要危险因素,年龄增加也是危险因素。

关键数值与推荐

  • 推荐对50至80岁、≥20包年吸烟史且目前吸烟或戒烟不足15年者每年行LDCT筛查(B级推荐)。
  • 戒烟满15年或出现严重限制预期寿命、或无法/不愿接受治愈性肺手术的健康问题时,应停止筛查。
  • 本推荐替代2013年USPSTF声明(55至80岁、≥30包年、现吸烟或戒烟不足15年)。

临床怎么用

  • 对符合年龄、包年与戒烟年限标准的高危成人,应每年提供LDCT筛查并在戒烟满15年或出现严重限制预期寿命/手术耐受性问题时停止。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Lung cancer is the second most common cancer and the leading cause of cancer death in the US. In 2020, an estimated 228 820 persons were diagnosed with lung cancer, and 135 720 persons died of the disease. The most important risk factor for lung cancer is smoking. Increasing age is also a risk factor for lung cancer. Lung cancer has a generally poor prognosis, with an overall 5-year survival rate of 20.5%. However, early-stage lung cancer has a better prognosis and is more amenable to treatment. OBJECTIVE: To update its 2013 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review on the accuracy of screening for lung cancer with low-dose computed tomography (LDCT) and on the benefits and harms of screening for lung cancer and commissioned a collaborative modeling study to provide information about the optimum age at which to begin and end screening, the optimal screening interval, and the relative benefits and harms of different screening strategies compared with modified versions of multivariate risk prediction models. POPULATION: This recommendation statement applies to adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. EVIDENCE ASSESSMENT: The USPSTF concludes with moderate certainty that annual screening for lung cancer with LDCT has a moderate net benefit in persons at high risk of lung cancer based on age, total cumulative exposure to tobacco smoke, and years since quitting smoking. RECOMMENDATION: The USPSTF recommends annual screening for lung cancer with LDCT in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery. (B recommendation) This recommendation replaces the 2013 USPSTF statement that recommended annual screening for lung cancer with LDCT in adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Krist AH, Davidson KW, Mangione CM, et al. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021. PMID: 33687470. doi:10.1001/jama.2021.1117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。